HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mizuho Ishikawa Selected Research

SI-591

12/2015Effect of SI-591, a new class of cathepsin K inhibitor with peptidomimetic structure, on bone metabolism in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mizuho Ishikawa Research Topics

Disease

2Neoplasms (Cancer)
01/2022 - 01/2019
1Renal Cell Carcinoma (Grawitz Tumor)
11/2020
1Bisphosphonate-Associated Osteonecrosis of the Jaw
01/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2019
1Neoplasm Metastasis (Metastasis)
01/2019
1Postmenopausal Osteoporosis
12/2015
1Bone Resorption
12/2015

Drug/Important Bio-Agent (IBA)

1Sunitinib (Sutent)FDA Link
11/2020
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2020
1Tyrosine Kinase InhibitorsIBA
11/2020
1Diphosphonates (Bisphosphonates)IBA
01/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020
1Small Interfering RNA (siRNA)IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Cathepsin KIBA
12/2015
1CalciumIBA
12/2015
1SI-591IBA
12/2015

Therapy/Procedure

1Therapeutics
01/2022